EVH - NYSE
Evolent Health, Inc.
$3.78
-4.5%Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.
At a Glance
Live SnapshotEvolent Health, Inc. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.
CapEx Intensity
Very high capital intensity consumes most operating cash flow. Limited flexibility for dividends or debt reduction.
FCF Growth Trend
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Working Capital Impact
Significant working capital drain. Growth may be consuming cash through inventory buildup or receivables extension—monitor closely.
Cash Flow Quality Insight
Capital-intensive growth: Heavy reinvestment limits current cash available but may drive future returns. Assess whether CapEx supports compelling growth opportunities with adequate ROI.
Evolent Health, Inc. Cash Flow Statement
EVH • NYSE
| Evolent Health, Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||||||
-579.4M | -61.6M | -113M | -19.2M | -37.6M | -328.2M | -305.6M | -54.2M | -69.8M | -226.8M | 319.8M | -25.2M | 20M | -19.3M | |
122.6M | 125.6M | 123.4M | 67.2M | 60M | 60.8M | 60.9M | 44.5M | 32.4M | 17.2M | 7.2M | 0.0 | 1.2M | 114K | |
-3M | -2.8M | -31.3M | 342K | -526K | -1.1M | -23.1M | 44K | -7.3M | -10.8M | 23.5M | 0.0 | 4.2M | 0.0 | |
39.7M | 39.7M | 40.5M | 34M | 16.7M | 0.0 | 15.6M | 17.6M | 20.4M | 22.5M | 14.7M | 0.0 | 91K | 87K | |
516.2M | 34.4M | 101.1M | 10.5M | 22.6M | 307.6M | 209.2M | 6.2M | 3.6M | 166.7M | -387.2M | 75.1M | -45.4M | 6.4M | |
(0.0) | (1.4M) | (4.9M) | (1.4M) | (551K) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
-57.4M | -116.6M | 21.9M | -104.4M | -22.5M | -55.3M | 331K | -34.9M | -7.3M | -4.4M | 2.2M | -49.9M | 6.2M | -1.8M | |
38.8M | 18.8M | 142.6M | -11.6M | 38.7M | -16.2M | -42.6M | -20.7M | -28M | -35.5M | -19.8M | -75.1M | -13.6M | -12.8M | |
INVESTING ACTIVITIES | ||||||||||||||
-34.1M | -24.9M | -28.7M | -38.4M | -25M | -31.8M | -35.5M | -39.6M | -27.8M | -15.5M | -6.5M | -11M | -10.4M | -2.3M | |
(0.0) | (0.0) | (870K) | (5.6M) | (14.2M) | -300K | -96.1M | -139.6M | -4.8M | -85.6M | (13.1M) | (0.0) | -15.5M | (0.0) | |
-1M | -7.3M | (0.0) | -5.6M | -3M | -11.2M | -11.1M | -10M | -3.8M | -9.1M | -54.2M | (0.0) | (0.0) | (0.0) | |
0.0 | 0.0 | 0.0 | 5.6M | 500K | 143.4M | 2.6M | 349K | 44.2M | 9.4M | 4M | 0.0 | 0.0 | 0.0 | |
34.9M | -30.7M | -387.7M | -226.3M | -2.5M | 160.9M | -41.5M | 28.4M | -20M | -6.1M | -50.2M | 7.5M | 50K | -1.5M | |
-233K | -62.9M | -415.5M | -259.1M | -15.8M | (261.1M) | -181.6M | -160.4M | -12.3M | -97.8M | -43.7M | -3.6M | -25.9M | -3.8M | |
FINANCING ACTIVITIES | ||||||||||||||
-40M | 3.5M | 0.0 | -18.3M | 0.0 | 2.6M | -2.6M | 0.0 | 166.9M | 1.3M | 209.1M | 0.0 | 0.0 | 4.5M | |
65.1M | 58.6M | 183.3M | 219.7M | -37.7M | 13.5M | 62.6M | 167.2M | 0.0 | 121.3M | 0.0 | 0.0 | 23M | 0.0 | |
-11.1M | -20.1M | -18.8M | (0.0) | -1.3M | -20M | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
-40M | (0.0) | (0.0) | -18.3M | (0.0) | (0.0) | -2.6M | -1.2M | (0.0) | -365K | (0.0) | (0.0) | -100K | (0.0) | |
-49.9M | -42.5M | -51.2M | -69.9M | 9.4M | -7.9M | -95.6M | 106.8M | -1.4M | -365K | -1.2M | -1.4M | 0.0 | 0.0 | |
-35.9M | -565K | 281.3M | 131.5M | -29.5M | -11.9M | -35.5M | 274M | 165.6M | 122.1M | 209.2M | -1.4M | 34.3M | 4.5M | |
CASH FLOW SUMMARY | ||||||||||||||
11.8M | -229K | -79K | -657K | -52K | -20M | 30K | -36K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
14.5M | -45M | 8.3M | -139.8M | -6.6M | 213M | -259.8M | 93M | 125.3M | -11.2M | 145.7M | -80M | -5.3M | -12M | |
163.5M | 223.5M | 215.2M | 354.9M | 361.6M | 120.4M | 388.3M | 295.4M | 170M | 145.7M | 0.0 | 0.0 | 5.3M | 17.3M | |
178M | 178.5M | 223.5M | 215.2M | 354.9M | 333.4M | 128.5M | 388.3M | 295.4M | 134.6M | 145.7M | -80M | 0.0 | 5.3M | |
4.8M | -6.1M | 113.8M | -49.9M | 13.8M | -45.7M | -78.2M | -60.2M | -55.8M | -51M | -26.3M | -86.1M | -24.1M | -15.1M |
SEC Filings
EVH - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 07, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 07, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 24, 2026 | June 04, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 25, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 24, 2026 | February 24, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 08, 2025 | December 05, 2025 | 2025 | |
8-K 8-K 2025 N/A | December 02, 2025 | December 01, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 07, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 06, 2025 | November 06, 2025 | 2025 | |
8-K 8-K 2025 N/A | September 23, 2025 | September 23, 2025 | 2025 |
Related Guides
Continue your EVH research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.